Literature DB >> 8630224

Growth factors as mediators of androgen action during male urogenital development.

G R Cunha1.   

Abstract

Studies on the developing prostate and seminal vesicle suggests that androgens act via mesenchymal androgen receptors to elicit synthesis and secretion of keratinocyte growth factor and probably other paracrine factors that regulate epithelial growth and morphogenesis. Clearly, the overall regulation of prostatic epithelial growth and ductal branching morphogenesis is complex and multifactorial, involving the interaction of both positive and negative regulators, extracellular matrix, cell surface receptors for growth factors, and vascularization. Future progress in our understanding of normal and abnormal prostatic growth will certainly be dependent upon the utilization of appropriate, biologically relevant models to examine the respective roles of these complex developmental process.

Mesh:

Substances:

Year:  1996        PMID: 8630224

Source DB:  PubMed          Journal:  Prostate Suppl        ISSN: 1050-5881


  11 in total

1.  Human stroma and epithelium co-culture in a microfluidic model of a human prostate gland.

Authors:  L Jiang; F Ivich; S Tahsin; M Tran; S B Frank; C K Miranti; Y Zohar
Journal:  Biomicrofluidics       Date:  2019-11-20       Impact factor: 2.800

2.  Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Authors:  Harold D Love; S Erin Booton; Braden E Boone; Joan P Breyer; Tatsuki Koyama; Monica P Revelo; Scott B Shappell; Jeffrey R Smith; Simon W Hayward
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

3.  Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.

Authors:  Xiaohong Li; Julie A Sterling; Kang-Hsien Fan; Robert L Vessella; Yu Shyr; Simon W Hayward; Lynn M Matrisian; Neil A Bhowmick
Journal:  Mol Cancer Res       Date:  2012-01-30       Impact factor: 5.852

4.  Estrogen stimulation of ovarian surface epithelial cell proliferation.

Authors:  W Bai; B Oliveros-Saunders; Q Wang; M E Acevedo-Duncan; S V Nicosia
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

5.  Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.

Authors:  S B Shappell; S Manning; W E Boeglin; Y F Guan; R L Roberts; L Davis; S J Olson; G S Jack; C S Coffey; T M Wheeler; M D Breyer; A R Brash
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

6.  Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate.

Authors:  Beatrice S Knudsen; Jared M Lucas; Ladan Fazli; Sarah Hawley; Seth Falcon; Ilsa M Coleman; Dan B Martin; Chang Xu; Lawrence D True; Martin E Gleave; Peter S Nelson; Gustavo E Ayala
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

7.  The smooth muscle gamma-actin gene is androgen responsive in prostate epithelia.

Authors:  R A Filmore; D A Dean; W E Zimmer
Journal:  Gene Expr       Date:  2002

8.  Effect of dexamethasone and testosterone treatment on the regulation of insulin-degrading enzyme and cellular changes in ventral rat prostate after castration.

Authors:  Juliany S B César Vieira; Karina L A Saraiva; Maria C L Barbosa; Regina C C Porto; Juan C Cresto; Christina A Peixoto; Maria I Wanderley; Daniel P Udrisar
Journal:  Int J Exp Pathol       Date:  2011-04-21       Impact factor: 1.925

9.  Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-Reductase Inhibition in Prostate Epithelial Cells.

Authors:  Teresa T Liu; Melanie J Grubisha; Krystle A Frahm; Stacy G Wendell; Jiayan Liu; William A Ricke; Richard J Auchus; Donald B DeFranco
Journal:  J Biol Chem       Date:  2016-05-13       Impact factor: 5.157

Review 10.  The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.

Authors:  Bandana Chatterjee
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.